·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 14, 2022

In the news: Overdose deaths surge to a record high, older adults need second Pfizer COVID-19 booster and more.

Publications & Newsletters
·
2 Min Read

March 18, 2022: State Advocacy Update

Maryland bill would direct opioid litigation settlement funds to public health and treatment and more in the State Advocacy Update.

Advocacy Update
Person in grocery aisle
·
4 Min Read

Removing naloxone’s Rx status is an essential step to save lives

As the drug-overdose epidemic worsens, there is no moral, medical or safety-related reason for keeping naloxone locked under prescription regulations.

Behavioral Health
Stethoscope draping a red toolkit
·
4 Min Read

Toolkit packed with evidence to help end drug-overdose epidemic

Some state officials are leading the way with science-driven policy that saves lives. It’s time their colleagues follow suit. Learn more with the AMA.

Behavioral Health
·
3 Min Read

Feb. 18, 2022: State Advocacy Update

New toolkit highlights effective policies in combating drug overdoses and more in the latest State Advocacy Update.

Advocacy Update
·
2 Min Read

AMA urges Administration to remove naloxone from behind the counter

Removing the prescription status of naloxone as an essential step to save lives from opioid-related overdose, helps to make naloxone available to patients.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Feb. 7, 2022

In the news: New opioid prescribing guidelines, mask effectiveness against COVID-19, nonopioid pain management and more.

Publications & Newsletters
·
2 Min Read

AMA welcomes draft CDC changes in opioid guidance

The AMA applauds the CDC for acknowledging the original guideline missed the mark.

Press Releases
·
3 Min Read

AMA, Manatt Health unveil toolkit to combat drug overdoses

The AMA and Manatt Health release a toolkit to guide states on removing barriers to evidence-based patient care.

Press Releases